United States · FDA National Drug Code directory
Midazolam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76045-211_ec9c9aee-b95f-4645-bf17-df7f1e3967d3
- Product NDC
- 76045-211
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Midazolam Hydrochloride
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210416
- Source listing expiry
- 20261231
Source-listed ingredients
- MIDAZOLAM HYDROCHLORIDE — 2 mg/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 24 BLISTER PACK in 1 CARTON (76045-211-20) / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-211-00) / 2 mL in 1 SYRINGE, GLASS · 76045-211-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →